PER 0.00% 8.0¢ percheron therapeutics limited

Go it alone or do a deal??, page-43

  1. 84 Posts.
    lightbulb Created with Sketch. 42
    Okay I admit I should've clarified that currently there is a 2 year deadline for approval that has only been recently stated - that's useful for everyone to know - although there has been talk that this deadline will be lifted, and in the past, RPDD approval + drug approval = voucher.

    Its also important to note that there is a bill currently that aims to extend this deadline to 2026.

    Calling my responses to your questions "utter rubbish" doesn't add much to this debate

    All I am trying to do is counter the misguided negativity that everyone else seems to put up with, ANP has a strong pipeline, with clear pathophysiological mechanism for action and promising efficacy results, good safety profile, and a motivated management team doing their best with modest cash balances. Hearing people who seem to appear like they are authorities on this topic, smear and degrade the company just irritates me and it should irritate you too if you are an investor.

 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.0¢
Change
0.000(0.00%)
Mkt cap ! $72.12M
Open High Low Value Volume
7.9¢ 8.0¢ 7.9¢ $12.63K 158.7K

Buyers (Bids)

No. Vol. Price($)
2 66500 7.6¢
 

Sellers (Offers)

Price($) Vol. No.
8.0¢ 273231 2
View Market Depth
Last trade - 15.26pm 19/07/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.